Phosphorylation of Canine Distemper Virus P Protein by Protein Kinase C-ζ and Casein Kinase II  by Liu, Zheng et al.
VIROLOGY 232, 198–206 (1997)
ARTICLE NO. VY978548
Phosphorylation of Canine Distemper Virus P Protein
by Protein Kinase C-z and Casein Kinase II
Zheng Liu,* Clayton C. Huntley,† Bishnu P. De,† Tapas Das,† Amiya K. Banerjee,† and Michael J. Oglesbee*,1
*Department of Veterinary Biosciences, The Ohio State University, 1925 Coffey Road, Columbus, Ohio 43210; and †Department of Molecular
Biology, Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195
Received February 10, 1997; returned to author for revision March 3, 1997; accepted March 21, 1997
Transcription by nonsegmented negative-strand RNA viruses is mediated by the viral RNA-dependent RNA polymerase
and transcriptional cofactor P. The P protein is activated by phosphorylation, an event initiated by cellular kinases. The
kinase used differs among this group of RNA viruses; vesicular stomatitis virus and respiratory syncytial virus utilize casein
kinase II (CKII), whereas human parainfluenza virus type 3 utilizes PKC isoform zeta (PKC-z) for activation of its P protein.
To identify the cellular kinase(s) involved in the phosphorylation of the canine distemper virus (CDV) P protein, we used
recombinant CDV P in phosphorylation assays with native kinase activities present in CV1 cell extracts or purified CKII and
PKC isoforms. Here, we demonstrate that the CDV P protein is phosphorylated by two cellular kinases, where PKC-z has
the major and CKII the minor activities. In contrast, the P protein of another member of the morbillivirus genus, measles
virus, is phosphorylated predominantly by CKII, whereas PKC-z has only minor activity. Selective inhibition of PKC-z activity
within CV1 cells eliminated permissiveness to CDV replication, indicating an in vivo role for PKC-z in the virus replication
cycle. The broad tissue expression of PKC-z parallels the pantropic nature of CDV infections, suggesting that PKC-z activity
is a determinant of cellular permissiveness to CDV replication. q 1997 Academic Press
INTRODUCTION and the formation of an active polymerase complex (Das
et al., 1995a; Gao and Lenard, 1995). The role of LAK in
The transcription and genomic replication of nonseg-
VSV transcription/replication remains to be determined.
mented negative-strand RNA viruses is mediated by a
The particular cellular kinase responsible for the P0virus-encoded RNA-dependent RNA polymerase com-
phosphorylation varies among negative-strand RNA vi-plex consisting of viral phosphoprotein (P) and RNA poly-
ruses, illustrated by members of the paramyxovirus fam-merase (L). The P protein is a transcription cofactor or a
ily. Human parainfluenza virus type 3 (HPIV3) utilizes ex-transactivator for L (Curran et al., 1992; De et al., 1991;
clusively protein kinase C-z for P0 phosphorylation (DeHamaguchi et al., 1983; Takacs et al., 1995). In vesicular
et al., 1995; Huntley et al., 1995). In situ inhibition ofstomatitis virus (VSV), a prototype for negative-strand
PKC-z activity using an isoform-specific peptide inhibitorRNA viruses, P phosphorylation is initiated by cellular
eliminates cellular permissiveness to HPIV3 replication.kinases (Barik and Banerjee, 1991, 1992; Gao and Len-
Furthermore, PKC-z is incorporated into the HPIV3 virionard, 1995; Gupta et al., 1995). The initial phosphorylation
(De et al., 1995). For respiratory syncytial virus (RSV),of P (P0) is mediated by casein kinase II (CKII), resulting
CKII phosphorylates P0and is directly responsible for reg-in a structurally distinct form of P (P1). The P1 is then
ulating viral transcriptional activity in reconstituted sys-phosphorylated by an L-associated kinase (LAK) to be-
tems (Barik et al., 1995; Mazumder and Barik, 1994; Vil-come the fully phosphorylated P2 form (Barik and Ban-
lanueva et al., 1994). Casein kinase II was also shownerjee, 1992; Gao and Lenard, 1995). The essential role
to be the predominant source of measles virus (MV) P0of CKII in VSV transcription was demonstrated in recon-
phosphorylation using crude cell extracts as a source ofstituted systems, where purified ribonucleoprotein tem-
enzyme (Das et al., 1995b). However, a reconstitutionplates (i.e., N protein-encapsidated genomic RNA) were
system to show the requirement of CKII-mediated Pcombined with purified native L protein and a nonphos-
phosphorylation for transcription is not currently avail-phorylated recombinant P protein. The addition of CKII
able for MV. Protein kinase C recognition sites are pres-was necessary and sufficient to support VSV transcrip-
ent within the deduced amino acid sequence of the MVtion (Gao and Lenard, 1995). Phosphorylation of P by
P gene although their recognition by cellular kinases hasCKII results in P oligomerization which is, in turn, neces-
not been established.sary for the association of P with template and L protein
Analysis of the deduced amino acid sequence of the
canine distemper virus P gene reveals multiple CKII and1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (614) 292-6473. E-mail: oglesbee.1@osu.edu. PKC (non-isoform-specific) recognition sites. The close
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structural relatedness of canine distemper virus (CDV) AGT AAT ACT TTT GAC) primers. Primers were synthe-
sized by Operon Technologies, Inc. (Alameda, CA). Theand MV P proteins (Rima, 1983; Yamanaka et al., 1992)
suggests similar kinase utilization for P0 phosphorylation. PCR incubation (Perkin–Elmer Thermal Cycler) con-
sisted of 24 thermal cycles, each cycle including denatur-However, the heterogeneity of kinase utilization by the
paramyxoviruses requires that this prediction be sub- ation at 947 for 2 min, annealing at 507 for 2 min, and
elongation at 727 for 2 min. A 5-min initial denaturationstantiated and the potential relevance of PKC phosphory-
lation events be addressed. The objective of the present and an additional elongation period of 5 min following
the last cycle were also incorporated.work was to identify cellular kinase(s) phosphorylating
the CDV P protein, to compare these phosphorylation The CDV P gene cDNA was gel purified, restricted with
HindIII and NdeI, then ligated into HindIII/NdeI linearizedevents to those of MV P protein, and to establish the
relevance of these kinase activities to CDV replication. pET-17b (Novagen) expression vector. This vector con-
tains an ampicillin-resistance marker (bla) and a bacte-
rial origin of replication, allowing its use in the amplifica-MATERIAL AND METHODS
tion of the construct. The ligation reaction product was
Virus–cell systems transformed into E. coli DH5-a for screening and amplifi-
cation. Desired constructs were identified by restrictionThe Onderstepoort strain of canine distemper virus
analysis using BamHI; restriction maps of the P gene(Ond-CDV) was used to infect continuous cell lines de-
and vector predict the release of a 4- and a 0.91-kbrived from African green monkey kidney: Vero (ATCC
fragment following BamHI digestion. Desired constructsCCL81) and CV1 (ATCC CCL70). Both cell lines support
were introduced into E. coli BL21(DE3) cells for the pro-equivalent degrees of cytopathic and productive infection
duction of P protein. The DE3 cells contain a T7 RNAby Ond-CDV. CDV-infected cells were used as a source
polymerase gene under control of a lacUV5 promoter;of viral nucleocapsid (NC)/genomic RNA for the produc-
the pET-17b vector contains a strong T7 RNA polymerasetion of a full-length P gene cDNA, while uninfected cells
promoter directed at the polylinker. The pET-17b-CDVP-were used as a source of cellular kinases in the phos-
containing DE3 cells were grown at 377 in LB mediaphorylation of recombinant CDV and MV P protein. Cells
containing 100 mg/ml ampicillin and 0.3% glucose. Pro-were grown at 377 in complete Eagle’s essential medium
duction of P protein was then induced with 1 mM IPTGsupplemented with 10% FCS.
for 2 hr and the recombinant P protein recovered by Ni-
affinity chromatography as previously described (De etProduction of recombinant CDV P in Escherichia coli
al., 1995). Column fractions were resolved by 10% SDS–
PAGE followed by both Coomassie staining and WesternThe production and characterization of recombinant
P protein from the Edmonston strain of MV has been blot analysis using CDV P monospecific hyperimmune
serum (Oglesbee et al., 1989b).described (Das et al., 1995b). For the production of a
nonphosphorylated recombinant CDV P protein, the Ond-
CDV NC was purified by CsCl isopycnic centrifugation as Purification of cellular kinase activities
previously described (Oglesbee et al., 1989a,b). Genomic
RNA was isolated by resuspending NC in TE buffer (10 The cellular kinase activities phosphorylating the re-
combinant CDV and MV P proteins were purified frommM Tris–HCl, pH 8.0, 1 mM EDTA) containing 0.6% SDS
and 0.2 mg/ml proteinase K, incubating the mixture at cytoplasmic extracts of CV1 cells using DEAE-cellulose
and phosphocellulose ion-exchange chromatography as377 for 20 min, and then using two rounds of phenol/
chloroform extraction. The full-length genomic RNA was previously described (De et al., 1995). Measurement of
phosphorylation was based upon the incorporation ofused as template for the reverse transcription (RT)-PCR
amplification of the P gene. The initial RT reaction con- [g-32P]ATP into nonphosphorylated recombinant P0 (see
below). Twenty million CV1 cells were disrupted into 10tained 50 mM Tris–HCl (pH 8.5), 8 mM MgCl2, 30 mM
KCl, 1 mM DTT, 1 mM dNTPs, 2 units/ml AMV reverse ml of 10 mM Tris–HCl, pH 7.5, 10 mM NaCl using two
freeze–thaw cycles. The lysate was clarified at 10,000gtranscriptase (Boehringer Mannheim, Germany), 1.25 U/
ml RNase inhibitor, and 25 ng/ml primer CDV-P5 (5*-GCG for 10 min and then at 100,000 g for 1 hr (Beckman
Ultracentrifuge, SW50 rotor). The clarified lysate was thenCCA TAT GGC AGA GGA ACA GGC CTA C). The reaction
was incubated at 377 for 30 min followed by heat inactiva- dialyzed against buffer A [50 mM Tris–HCl (pH 7.5), 50
mM NaCl, 5% v/v glycerol, 0.1 mM EDTA, 1 mM DTT] fortion at 857 for 10 min. The reaction product was then
used as template for the PCR amplification of P gene 12 hr and then adsorbed to the DEAE-cellulose column
(DE52). This column was developed using a linear gradi-cDNA. The reactions contained 10 mM Tris–HCl (pH 8.3),
1.5 mM MgCl2, 50 mM KCl, 1 mM dNTPs, 0.01 U/ml Taq ent of 0–0.4 M NaCl in buffer A. The fractions supporting
P phosphorylation were pooled and adsorbed onto theDNA polymerase (Boehringer Mannheim), and 5 ng/ml of
both the 5* (CDV-P5) and 3* (CDVP3His; 5*-CCC AAG phosphocellulose column and the column developed by
a linear 0.2–1.0 M NaCl gradient.CTT TTA ATG ATG ATG ATG ATG ATG ATG AGC ATG
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In vitro phosphorylation of CDV and MV P using CV1- (Quality Controlled Biochemicals, Inc.) were delivered
into cells using a lipid-based peptide delivery systemorigin kinase
(TransPort transient cell permeabilization kit; Gibco BRL).
In vitro phosphorylation of 1 mg CDV or MV P protein Subconfluent monolayers of cells in 24-well plates were
was performed under reaction conditions optimal for either incubated at 377, 15 min, with varying concentrations of
CKII or PKC. The CKII reactions contained 50 mM Tris– peptide A or Z (0, 1, 2, 3, 4, or 5 mM) in the peptide
HCl (pH 7.5), 10 mM MgCl2 , 100 mM NaCl, 2 mM DTT, delivery buffer system. The peptide-containing buffer was
33.3 mM ATP, and 10 mCi [g-32P]ATP. PKC reactions differed then replaced by fresh MEM medium with 10% FCS. Cells
in that the salt concentration was low (20 mM Tris–HCl were allowed to recover at 377 for 45 min, then infected
and no NaCl), BSA was added (0.25% w/v), and PKC cofac- with Ond-CDV at a multiplicity of infection (m.o.i.) of 0.01.
tors were added as indicated, including 0.1 mg/ml phospha- Viral progeny were harvested at 24 hr postinfection using
tidylserine (PS), 0.5 mM CaCl2 , 0.1 mg/ml diacylglycerol two freeze–thaw cycles and titrated in a plaque forming
(DAG). The PS and DAG were dissolved in 10 mM CHAPS assay.
prior to addition to the reactions; detergent does not influ-
ence kinase activity in these assays. For the analysis of RESULTS
kinase activities within crude cell extracts, a CKII buffer
Cloning of the CDV-P gene and purification ofsystem supplemented with PKC cofactors was used since
recombinant P protein from E. colithese conditions will readily support both CKII and PKC
activity. The volume of cell extract used in these reactions The phosphoprotein P of negative-strand RNA viruses
(1 ml) was established empirically. Reactions were incu- is phosphorylated when purified from infected cells (Ban-
bated at 307 for 1 hr and resolved by 10% SDS–PAGE erjee et al., 1991; Rima, 1983). However, when the P
followed by autoradiography. protein of VSV, HPIV3, and MV is expressed in bacteria
(E. coli), the recombinant P remains nonphosphorylated
In vitro phosphorylation of CDV and MV P using (Barik and Banerjee, 1991; Das et al., 1995b; De et al.,
exogenous kinase 1995) and is suitable for the in vitro analysis of kinase
activities. Therefore, prokaryotic expression of recombi-Recombinant kinases and kinases purified from cells
nant P was used to analyze CDV P phosphorylation.other than CV1 were used in the phosphorylation of re-
A full-length cDNA clone of the CDV-P gene was gen-combinant CDV and MV P protein and recombinant P
erated by RT-PCR of genomic RNA purified from nucleo-proteins from other negative-strand RNA viruses to sup-
capsids. The primers were designed to add an NdeI siteport results of experiments using CV1 cell extracts. The
overlapping the initiator methionine codon AUG, and aenzymes included recombinant CKII (New England Bio-
HindIII site 3* to the P gene. This design allowed cloningLabs, Beverly, MA), recombinant PKC-a, recombinant
of the RT-PCR product into unique sites in the expressionPKC-h, recombinant PKC-z (Goodnight et al., 1995), and
vector. The RT-PCR primers were also designed to addmixed isoforms of PKC isolated from rat brain (Boeh-
a seven-histidine tag to the carboxyl terminus of the re-ringer Mannheim). A filter-binding assay was used to
combinant P protein, facilitating purification of the recom-establish the relative activity of the specific PKC isoforms
binant protein by Ni-affinity chromatography. The RT-PCR(i.e., PKC-a, PKC-h, and PKC-z) so that reactions could
product migrated as a single 1.6-kb band on a 1% agar-be established containing equivalent activities of each
ose gel (data not shown), matching the size of the P geneenzyme. One and two microliters of each recombinant
(1631 bp). The structure of the recombinant plasmid (pET-PKC isoform was used under the PKC reaction conditions
17b-CDVP) was confirmed by restriction analysis usingdescribed above, using as substrate the synthetic pep-
BamHI, in which a 4.0- and 0.91-kb band were visualizedtide [Ser25]PKC-(19-31), designated peptide a (Kochs et
by ethidium bromide staining (data not shown), matchingal., 1993). Peptide a is recognized equally by these PKC
the size of restriction fragments predicted from sequenceisoforms. Reaction products were spotted onto phospho-
analysis of the CDV P gene and pET-17b vector.cellulose paper, unincorporated radioactivity removed by
Expression of recombinant CDV P protein was inducedwashing in 0.35% phosphoric acid (5 min 1 2), and the
by IPTG after the pET-17b-CDVP-transformed DE3 cellsdegree of peptide phosphorylation measured by liquid
were grown to optimal density. When bacterial cell ex-scintillation counting.
tracts were fractionated on a Ni-affinity column, a promi-
nent doublet with an average molecular mass of 75 kDaIn vivo inhibition of protein kinase C activity
was observed in fractions 2–7 by 10% SDS–PAGE (data
not shown). To further characterize the purified protein,Peptide inhibitors of PKC isoforms were introduced
into CV1 cells prior to Ond-CDV infection. Peptide A CDV P-specific hyperimmune serum was used in West-
ern blot analysis of both recombinant P and native P(RKGALRQKN) inhibits conventional PKC isoforms (e.g.,
PKC-a, PKC-b, and PKC-g). Peptide Z (RRGARRWRK) se- contained in purified nucleocapsid. The same protein
doublets of approximately 75 kDa were recognized inlectively inhibits PKC-z activity. These two peptides
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mediated predominantly by a CKII-like activity, consistent
with previously published results (Das et al., 1995b).
Cell extracts were then fractionated, purifying the ki-
nase activities in order to identify the specific kinases
responsible for the observed activity. Crude extracts of
CV-1 cells were fractionated through a DE52 column. The
recombinant CDV and MV P0 was phosphorylated by
fractions eluted with 0.25 M NaCl (data not shown).FIG. 1. Kinase activity of crude cytoplasmic extracts of CV1 cells
The active fractions were pooled and passed through ausing CDV and MV recombinant P protein as substrate. Reactions were
phosphocellulose column. The bound proteins wereperformed using CKII buffer conditions containing PKC cofactors and
[g-32P]ATP. The P proteins were resolved by 10% SDS–PAGE and the eluted from the column by a 0.2–1.0 M NaCl linear gradi-
phosphorylated reaction products visualized by autoradiography. The ent. Interestingly, both CDV and MV P phosphorylating
75-kDa CDV P protein and the 70-kDa MV P protein were phosphory-
activity was detected in both the unbound (flowthrough)lated by the kinase(s) present in the extract. Staurosporine (S) (400
and bound fractions with peak activities in fraction num-nM) and heparin (H) (20 mg/ml) were added to reactions as indicated.
bers 25–35, as illustrated in Fig. 2. The unbound and
pooled bound fractions were used in all subsequent ex-
both preparations, suggesting a similar structure be- periments. The phosphorylation of CDV and MV P by the
tween the recombinant and the native P proteins (data unbound fraction was inhibited by 400 nM staurosporine,
not shown). The tendency of native P protein of morbillivi- while 20 mg/ml heparin had no effect on this activity (Fig.
ruses to migrate as a doublet has been reported (Graves, 3). Conversely, the kinase activity in peak fraction 30 was
1981; Rima, 1983). The average size of the P doublet is inhibited by 20 mg/ml heparin while staurosporine had
larger than the predicted molecular mass of CDV P (66 no effect (Fig.3). These data suggested that both PKC
kDa). This discrepancy between the observed and the (unbound fraction) and CKII (bound fraction) are involved
predicted molecular mass of CDV P has been docu- in the phosphorylation of CDV and MV P protein. Phos-
mented in previous work (Oglesbee et al., 1989a) and is phorylation of MV P by PKC was found to be highly sensi-
similar to the aberrant migratory pattern of the VSV P tive to phosphatase activity present in crude cell extracts
protein (Barik and Banerjee, 1991). (data not shown), suggesting a basis for the detection of
only minor PKC activities when using crude extract in
MV P phosphorylation reactions.CDV and MV P was phosphorylated by PKC and CKII-
To determine whether phosphorylation by one kinaselike activities in CV1 extracts
Crude cytoplasmic extracts and cytoplasmic extracts
fractionated by DEAE-cellulose and phosphocellulose
chromatography were used to identify the cellular ki-
nase(s) that phosphorylates CDV P and, for comparison,
MV P. For these kinase assays, recombinant CDV or
MV P0 protein was mixed with cytoplasmic extract under
buffer conditions optimal for both CKII and PKC activity
(i.e., CKII buffer supplemented with PKC cofactors), with
or without inhibitors of CKII (i.e., heparin) and PKC (i.e.,
staurosporine). In crude cell extracts, both CDV and MV P
were phosphorylated (Fig.1). The CDV P phosphorylation
was inhibited by 60% in the presence of staurosporine
(400 nM) and by 30% in the presence of heparin (20 mg/
ml). Similar results were obtained when using 200 nM
staurosporine and 8 mg/ml heparin (data not shown). In
contrast, MV P phosphorylation was inhibited by 20% in
the presence of staurosporine and by 90% in the pres-
FIG. 2. Isolation of kinase activities in cytoplasmic extracts of CV1
ence of heparin. For both CDV and MV, phosphorylation cells. The phosphocellulose column fractions were tested for their ki-
was totally inhibited when these two inhibitors were used nase activity using recombinant CDV or MV P as substrate. Reactions
were performed using CKII buffer conditions containing PKC cofactorsin combination. The magnitude of P phosphorylation was
and [g-32P]ATP. The CDV and MV P proteins were then resolved bybased upon 32P phosphorimager signal intensities of
10% SDS–PAGE and the phosphorylated proteins visualized by autora-SDS–PAGE banded reaction products. These results
diography. Prominent kinase activities were detected in the unbound
suggest that CDV P0 phosphorylation occurs via a pre- fraction (U) and by material retained on the column, then eluted by a
dominant PKC-like activity and a minor CKII-like activity. 0.2–1.0 M NaCl gradient. Numbers above lanes represent the eluant
fraction number.MV P0 phosphorylation, on the other hand, appears to be
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dylserine, diacylglycerol, and phorbol esters (Bell and
Burns, 1991; Nishizuka, 1988, 1992). Atypical PKCs (m, z,
and l) are dependent upon phosphatidylserine but are
not affected by calcium, diacylglycerol, or phorbol esters
(Nishizuka, 1992). Reactions were supplemented with
calcium or the calcium was depleted using 200 mM cal-
cium chloride or 500 mM EGTA, respectively. Phosphati-
dylserine was added at 100 mg/ml and the diacylglycerol
added to a final concentration 100 mg/ml. The kinase
activity in the unbound fraction did not require calcium orFIG. 3. Selective inhibition of kinase activity in unbound and peak
diacylglycerol but was stimulated by phosphatidylserinefractions of the phosphocellulose column. The kinase activities within
(Fig.4). These data indicated that the PKC isoform in-the unbound and peak fractions were tested for their sensitivity to
inhibition by heparin (H) or staurosporine (S), using recombinant CDV volved in phosphorylation of CDV and MV P belongs to
and MV P as substrate under CKII and PKC buffer conditions, respec- the atypical subgroup.
tively. Activities were compared to reactions containing no inhibitors Western blot analysis of the unbound and peak cyto-(0). The phosphorylated (32P-labeled) proteins were analyzed by 10%
plasmic fractions was performed to confirm the existenceSDS –PAGE and visualized by autoradiography. Kinase activity in the
of an atypical PKC in the unbound fraction and CKII inunbound fraction was inhibited by staurosporine but not heparin, con-
sistent with a PKC-like activity. Conversely, kinase activity in the peak the peak fraction. Five PKC isoform-specific polyclonal
fraction was inhibited by heparin but not staurosporine, consistent with antibody preparations were used (Gibco BRL), recogniz-
a CKII-like activity. ing a, b1/b2, g, e, and z. In the unbound fraction, specific
signal was demonstrated with only the anti-PKC-z anti-
body (i.e., a double band in which the lower component(i.e., PKC or CKII) influences phosphorylation by the other
has an approximate mass of 68 kDa) (Fig.5). Polyclonalkinase, equal amounts of CDV and MV P proteins were
antibody against CKII (Yu et al., 1991) detected a 42-used in reactions containing unbound and bound cell
kDa band in the peak bound fraction (data not shown),fractions, separately or in combination. No synergistic
consistent with the mass of CKII and the CKII-like kinaseeffect was observed when the PKC- and CKII-containing
activity detected in this cell fraction.cell fractions were used in combination; phosphorylation
by PKC and CKII-like activities occurred independently.
CDV and MV P protein was phosphorylated byUnder optimal conditions for PKC and CKII activity, 1.0
exogenous PKC and CKIImol of phosphate was incorporated by the PKC-like activ-
ity and 0.3 mol by the CKII activity for each mole of CDV Protein kinase C purified from rat brain (mixed iso-
P substrate. The stoichiometry of phosphorylation was forms) and recombinant CKII were used to confirm the
established by measuring the degree of 32P incorporation role of PKC and CKII in mediating phosphorylation of
into P, where the specific activity of the [g-32P]ATP phos- recombinant CDV and MV P. Nonphosphorylated P sub-
phate donor and moles of P protein substrate were de- strate from VSV and HPIV3 which are specifically phos-
fined. In the case of MV, 2.0 mol of phosphate were phorylated by CKII and PKC, respectively, were included
incorporated by CKII and 0.1 mol by PKC for each mole as positive controls. The CDV, MV, and HPIV3 P proteins
of P substrate (data not shown). Incorporation of less
than 1 mol of phosphate per mole of P protein suggests
that only a small proportion of the latter becomes phos-
phorylated.
PKC-z and CKII were detected in cell fractions
phosphorylating CDV and MV P
In vitro phosphorylation assays were designed to de-
termine the cofactor requirements of the PKC-like kinase
activity in the unbound cytoplasmic fraction to determine
which isoform of PKC mediates CDV P phosphorylation.
At least 11 isoforms of PKC have been identified in mam- FIG. 4. Cofactor requirements of the kinase activity present in the
unbound fraction. Two microliters of the unbound fraction was used inmalian tissue: a, b1, b2, g, u, l, m, z, h, e, and d (Johannes
kinase reactions containing PKC buffer, [g-32P]ATP, and recombinantet al., 1994; Nishizuka, 1992). Amongst them, a, b1, b2,
CDV or MV P in presence (/) or absence (blank) of one or more ofand g are designated conventional PKCs and are acti-
the following: CaCl2 (200 mM), PS (100 mg/ml), DAG (20 mg/ml), andvated by calcium, phosphatidylserine, diacylglycerol, and EGTA (500 mM). The kinase activity in the unbound fraction was stimu-
phorbol esters. Novel PKCs (u, h, e, and d ) do not require lated by phosphatidylserine and was not dependent upon Ca2/ or
diacylglycerol, consistent with an atypical PKC.calcium for activation, but are stimulated by phosphati-
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FIG. 5. Western blot analysis of PKC isoforms in the unbound fraction.
Protein contained within unbound cell fractions phosphorylating CDV
and MV P were resolved by 10% SDS–PAGE and transferred to nitrocel-
lulose membranes, and the blots were developed using polyclonal
antibodies against PKC-a (a), PKC-b (b), PKC-g (g), PKC-e (e), and
PKC-z (z). Specific signal was detected by the anti-PKC-z antibody.
FIG. 7. Phosphorylation of recombinant CDV and MV P using purified
recombinant PKC isoforms. Equivalent active units of recombinant PKC
were phosphorylated by purified PKC (Fig. 6), and stauro- isoforms a, h, and z were combined with recombinant CDV or MV P
sporine (400 nM) inhibited the PKC activity. Recombinant in reactions containing [g-32P]ATP and using PKC buffer conditions.
The phosphorylated proteins were resolved by 10% SDS–PAGE andCKII phosphorylated the P protein of CDV, MV, and VSV
visualized by autoradiography. For each reaction, the 75-kDa CDV Pconsistent with the kinase activity observed in the phos-
protein is labeled to a degree proportionate to bands of lower molecularphocellulose bound fraction. The phosphorylation was mass, suggesting that the latter represent degradation products of the
inhibited by heparin at 20 mg/ml. The lesser degree of parental protein.
heparin-mediated inhibition of VSV and MV P phosphory-
lation may reflect a higher affinity of CKII for these recom-
mined the relative activity of these enzymes in a filterbinant viral proteins.
binding assay using their common pseudosubstrate,Recombinant PKC isoforms were used to support the
peptide a. The degree of peptide a phosphorylation,specific role of PKC-z in CDV and MV P phosphorylation.
measured by liquid scintillation counting, is used to de-Using recombinant a, h, and z isoforms, we first deter-
termine the relative activity of PKC isoform preparations.
The relative activity, by volume, of a, h, and z isoforms
was 3.5:1.0:11.4. This determination allowed the design
of subsequent reactions containing equivalent enzymatic
activities and recombinant CDV or MV P protein as sub-
strate. CDV and MV P were phosphorylated by PKC-z,
with lesser degrees of phosphorylation mediated by PKC-
h and PKC-a (Fig. 7). These results further support the
involvement of PKC-z in CDV and MV P phosphorylation.
In situ inhibition of PKC-z eliminates CDV replication
For VSV, RSV, and HPIV3, phosphorylation of P is pro-
posed as an essential step in the activation of the viral
polymerase (L) (Barik and Banerjee, 1991, 1992; De et
FIG. 6. Phosphorylation of recombinant CDV and MV P by recombi- al., 1995; Mazumder and Barik, 1994). Accordingly, in situ
nant CKII and purified PKC (mixed isoforms). Reactions were performed inhibition of PKC-z activity eliminates HPIV3 but not VSV
in the presence of heparin (H) or staurosporine (S), or in the absence replication, the latter being dependent upon CKII for P
of either inhibitor (0), to confirm the specificity of phosphorylation medi-
phosphorylation (De et al., 1995). In the present study,ated by the purified kinases. Recombinant P protein from HPIV3 was
pseudosubstrate peptide inhibitors of PKC-z (peptide Z)used as a positive control for PKC reactions, and recombinant P protein
from VSV was used as positive controls for CKII reactions. and conventional PKCs (peptide A) were used to deter-
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mine whether the PKC-z activity is relevant to CDV repli-
cation. These inhibitory peptides mimic PKC autoinhibi-
tory regions known as pseudosubstrate domains. Pep-
tide A has a sequence conserved in the pseudosubstrate
domain of PKC isotypes a, b, and g and is an inhibitor
of these isotypes when introduced into cells (Dominguez
et al., 1992). Peptide Z has a sequence identical to the
pseudosubstrate domain of PKC-z, being sufficiently dif-
ferent from the pseudosubstrate domains of PKC a, b,
and g to mediate selective inhibition of PKC-z within
cells (Dominguez et al., 1992). First, these two peptides
(i.e., peptide A and Z) were used at varying concentra-
tions (5–20 mM) in the in vitro phosphorylation of CDV
P by phosphocellulose unbound cell fraction. Peptide Z
inhibited phosphorylation of CDV P by more than 70% at
20 mM, whereas peptide A had no effect. Next these
peptides were delivered at varying concentrations into
subconfluent monolayers of CV1 cells using a lipid-based
FIG. 8. The effect of PKC-z inhibition on permissiveness of CV1 cellspeptide delivery system. Cells were infected at an m.o.i.
to CDV replication. CV1 cells in the logarithmic phase of growth were 0.01 following a 45-min cell recovery interval and viral treated with 0–5 mM peptide Z, a PKC-z inhibitor, or peptide A, an
progeny release was quantitated at 24 hr postinfection. inhibitor of conventional PKC isoforms. The peptides were introduced
into the cells using a lipid-based delivery system. Cells were treatedCells treated with 1–5 mM peptide A demonstrated virus-
for 15 min, allowed to recover for 45 min, and infected at an m.o.i. induced syncytia formation (plaque formation) compara-
0.01. Infectious viral progeny were quantitated at 24 hr postinfection.ble to the untreated infected controls, whereas cells
Peptide A treatment (l) did not affect viral progeny release. Peptide Z
treated with 1–5 mM peptide Z demonstrated a concen- treatment (j) caused a dosage-dependent reduction in progeny re-
tration-dependent reduction in plaque number and size lease. No viral progeny were produced at ¢ 3 mM peptide Z.
(data not shown). The effect of peptide treatment on in-
fectious viral progeny release was consistent with these
results (Fig. 8). Virus harvested from cells treated with 1 CDV and MV P contain multiple PKC consensus recogni-
tion sites (S/T-X-K/R; n  8 for Ond-CDV and n  7 formM peptide Z yielded 1200 PFU/1.5 1 105 cells, compa-
rable to viral progeny release from infected cells treated Edmonston MV).
Using fractionated cell extracts (Figs. 2–5), we demon-with 1–5 mM peptide A or untreated controls. At 2 mM
peptide Z, viral progeny release was decreased by 53% strate involvement of an atypical PKC in the phosphoryla-
tion of both CDV and MV P proteins. Protein kinase C-zand at 3 mM peptide Z viral progeny release was com-
pletely abolished. Peptide Z treatment did not affect via- was present in cell fractions containing the atypical PKC
activity based upon biochemical and antigenic analyses.bility of uninfected control cells.
Furthermore, both native PKC (mixed isoforms; Fig. 6)
and recombinant PKC-z (Fig. 7) phosphorylate CDV andDISCUSSION
MV P to a high degree of activity. Previous analysis of
MV P phosphorylation by native kinase, however, failedWe have demonstrated involvement of two cellular ki-
nases, CKII and PKC-z, in the phosphorylation of CDV P to detect PKC activity when using crude cytoplasmic ex-
tracts (Das et al., 1995b). In the current study, the atypicalprotein. Of the two kinases, PKC was detected as the
major and CKII as the minor activities in CDV P phosphor- PKC activity against MV P was readily detected only after
these crude preparations were further refined by ion-ylation by crude cell extracts (Fig.1). In contrast, MV P
phosphorylation was carried out predominantly by CKII, exchange chromatography. The disparity between re-
sults of using crude versus fractioned cell extracts ap-as reported previously (Das et al., 1995b). In the latter
work, CKII phosphorylation of MV P protein was shown pears to reflect the presence of phosphatase activity in
the crude extract.using both native enzyme contained in crude cell extracts
and recombinant CKII (Das et al., 1995b). In this regard, The biological relevance of PKC-z phosphorylation of
CDV P was supported by results of experiments usingphosphorylation of CDV and MV P differs despite the
biochemical similarity between these two proteins. The isoform-specific inhibition of PKC-z activity (Fig. 8). Pep-
tide Z, an inhibitor of PKC-z, inhibited in vitro CDV Pamino acid sequences of the CDV and MV P proteins
are 44% identical (Hall et al., 1980; Yamanaka et al., 1992), phosphorylation by fractionated cell extracts and caused
a dosage-dependent reduction in CV1 permissiveness toand both share multiple CKII consensus recognition sites
(S/T-X-X-D/E; n  10 for Ond-CDV and Edmonston MV). CDV replication. Peptide A, an inhibitor of conventional
PKC isoforms, had no effect in either of these assays.In addition, the deduced amino acid sequences of both
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Other reports document the ability of peptide Z to reduce Vero, Madin–Darby canine kidney, Madin–Darby bovine
kidney, porcine kidney, and murine neuroblastoma cellsthe in vitro activity of recombinant PKC-z, where peptide
A has no effect (De et al., 1995). Furthermore, peptide Z (unpublished observation). Thus, the expression of PKC-
z complements the broad cellular and tissue tropism ofinhibits HPIV3 replication when administered to CV 1
cells (De et al., 1995). The specificity of peptide Z for PKC CDV, suggesting that cellular PKC-z activity is an im-
portant determinant of permissiveness to CDV infection.and HPIV3/CDV replication is documented by the lack of
effect of peptide Z upon replication of VSV, a virus using
CKII for the phosphorylation activation of P (De et al., ACKNOWLEDGMENTS
1995). Down-regulation of PKC-z does not affect meta- The authors thank Dr. Walter Kolch for the recombinant PKC-a, h,
bolic pathways involved in cell proliferation (Berra et al., and z, and Dr. Daniel Marshak for the anti-CKII antibodies. This work
was supported by grants from The State of Ohio Canine Research1993; Diaz et al., 1993; Dominguez et al., 1992; Larrodera
Fund and National Institute of Neurologic Disorders and Stroke (R29et al., 1990), suggesting that the antiviral effect of PKC-
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